Kadmon Holdings Inc Revenue Growth Rates (KDMN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Kadmon holdings inc   (NASDAQ: KDMN)
 

KDMN's Revenue Growth by Quarter and Year

Kadmon Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KDMN Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December -
3rd Quarter September 14.71
2nd Quarter June 0.20
1st Quarter March 0.56
FY 15.47

KDMNs Annual Revenue
Kadmon Holdings Inc 's Revenue in the fiscal year 2020 $ 8.29 millions
Kadmon Holdings Inc 's Revenue in the fiscal year 2019 $ 5.10 millions
Kadmon Holdings Inc 's Revenue in the fiscal year 2018 $ 1.40 millions
Kadmon Holdings Inc 's Revenue in the fiscal year 2017 $ 12.26 millions
Kadmon Holdings Inc 's Revenue in the fiscal year 2016 $ 95.02 millions




KDMN Revenue third quarter 2021 Y/Y Growth Comment
Kadmon Holdings Inc showed record Revenue surge in the third quarter 2021 with 2901.22% from the third quarter 2021 2020, to $ 14.71 millions.

Looking into third quarter 2021 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Revenue growth. While Kadmon Holdings Inc ' s Revenue doubling of 2901.22% ranks overall at the positon no. 41 in the third quarter 2021.


KDMN Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December - -85.91 % 1813.04 % -84.25 %
3rd Quarter September 2901.22 % 113.04 % -37.84 % -83.77 %
2nd Quarter June -55.56 % 95.65 % -36.11 % -87.84 %
1st Quarter March -91.69 % 2708.33 % -44.19 % -92.28 %
FY   - 62.75 % 266.91 % -

Financial Statements
Kadmon Holdings Inc 's third quarter 2021 Revenue $ 14.71 millions KDMN's Income Statement
Kadmon Holdings Inc 's third quarter 2020 Revenue $ 0.49 millions Quarterly KDMN's Income Statement


KDMN Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - 26.53 % 1813.04 % -37.84 %
3rd Quarter September 7253 % 8.89 % 0 % 2.78 %
2nd Quarter June -64.29 % -93.32 % -4.17 % -16.28 %
1st Quarter March -9.68 % 53.18 % 4.35 % -70.55 %
FY (Year on Year)   - 62.75 % 266.91 % -


Back to KDMN Growth rate Comparisons >> Back to KDMN Growth rate Comparisons >>


Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #16
Overall #41

Revenue Y/Y Growth Statistics
High Average Low
2901.22 % 460.4 % -92.22 %
(Sep 30 2021)   (Mar 31 2018)
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #16
Overall #41
Revenue Y/Y Growth Statistics
High Average Low
2901.22 % 460.4 % -92.22 %
(Sep 30 2021)   (Mar 31 2018)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Kadmon Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
7364.97 % 494.69 % -93.35 %
(Sep 30 2021)  


KDMN's III. Quarter Q/Q Revenue Comment
Kadmon holdings inc achieved in the III. Quarter 2021 above company average sequential Revenue doubling of 7253%, to $ 14.71 millions, from $0.20 millions in the second quarter.
KDMN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Kadmon Holdings Inc 's Revenue growth quarter on quarter, overall rank is 15.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #6
Overall #15
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #6
Overall #15
Revenue Q/Q Growth Statistics
High Average Low
7364.97 % 494.69 % -93.35 %
(Sep 30 2021)  


KDMN's III. Quarter Q/Q Revenue Comment
Kadmon holdings inc achieved in the III. Quarter 2021 above company average sequential Revenue doubling of 7253%, to $ 14.71 millions, from $0.20 millions in the second quarter.
KDMN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Kadmon Holdings Inc 's Revenue growth quarter on quarter, overall rank is 15.


Kadmon Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)
Cumulative Revenue 12 Months Ending $ 16.08 $ 1.87 $ 2.12 $ 8.29 $ 12.08
Y / Y Revenue Growth (TTM) 33.18 % -84.21 % -81.74 % 62.67 % 1205.41 %
Year on Year Revenue Growth Overall Ranking # 42 # 3652 # 3416 # 106 # 14
Seqeuential Revenue Change (TTM) 762.25 % -11.86 % -74.47 % -31.36 % 2.24 %
Seq. Revenue Growth (TTM) Overall Ranking # 2668 # 2506 # 2884 # 2265 # 1198


Cumulative Revenue growth Comment
Although Kadmon Holdings Inc 's Annual Revenue growth year on year were below company's average 246.06% , Revenue announced in the Sep 30 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 33.18% year on year, from -84.21% in Jun 30 2021.

Among companies within the Healthcare sector 13 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 42, from total ranking in previous quarter at 3652.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 125
Healthcare Sector # 14
Overall # 42

Revenue TTM Y/Y Growth Statistics
High Average Low
1205.41 %
 246.06 %
-88.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 368
S&P 500 # 2668
Cumulative Revenue growth Comment
Although Kadmon Holdings Inc 's Annual Revenue growth year on year were below company's average 246.06% , Revenue announced in the Sep 30 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 33.18% year on year, from -84.21% in Jun 30 2021.

Among companies within the Healthcare sector 13 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 42, from total ranking in previous quarter at 3652.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 125
Healthcare Sector # 14
Overall # 42

Revenue TTM Y/Y Growth Statistics
High Average Low
1205.41 %
246.06 %
-88.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 368
S&P 500 # 2668




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
KDMN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2021
Cue Health Inc 4,628.94%$ 4,628.943 millions
Skinvisible Inc 4,369.16%$ 4,369.161 millions
Volitionrx Limited4,331.83%$ 4,331.826 millions
Syndax Pharmaceuticals Inc 3,165.17%$ 3,165.172 millions
Moderna Inc 3,046.73%$ 3,046.729 millions
Alector Inc 2,989.65%$ 2,989.651 millions
Kadmon holdings inc 2,901.22%$ 2,901.224 millions
Seer Inc 2,893.06%$ 2,893.056 millions
Anavex Life Sciences Corp 2,362.56%$ 2,362.560 millions
Biocardia Inc 2,314.71%$ 2,314.706 millions
Agenus Inc1,605.46%$ 1,605.461 millions
Dynavax Technologies Corporation1,534.47%$ 1,534.466 millions


About Kadmon Holdings Inc Revenue Growth Rates (KDMN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.